A recent toast to James Watson highlights a tolerance for bigotry many want excised from the scientific community.
Determining which products of advanced biotechnology are deserving of legal protections is essential to our own social architecture.
News & Opinion
Covering the life sciences inside and out
The finding confirms that a cluster of cells that directs the fate of other cells in the developing embryo is evolutionarily conserved across the animal kingdom.
Peer review varies in quality and thoroughness. Making it publicly available could improve it.
A recent toast to James Watson highlights a tolerance for bigotry many want excised from the scientific community.
The Nutshell
Daily News Roundup
Medical groups have criticized the legislation, which will give terminal patients access to experimental treatments, as dangerous and unnecessary.
A total of 27 people have died since April, but new funds and the deployment of an experimental vaccine are expected to help contain the virus.
Fruit bats are a reservoir for the disease, which can cause brain damage.
Early exposure to common microbes could stop leukemia from manifesting in children.
Current Issue
May 2018
When the O’Neills learned that their daughter had Sanfilippo syndrome, a devastating rare disease, they created a GoFundMe campaign that raised $2 million in less than a year.
Clinical analyses of patients’ gene sequences are helping to provide answers where none were available before.
Crowdfunding can power investigations into diseases that would otherwise receive little attention.
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Multimedia
Video, Slideshows, Infographics
Ali Guthy, the daughter of cosmetics entrepreneur Victoria Jackson, discusses NMO, the rare autoimmune disease she suffers from.
Watch the viral video that helped the family of a child with Sanfilippo syndrome raise more than $2 million.
The Marketplace
Sponsored Product Updates
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that its research collaboration with FIT Biotech Oy (FITBIO:FN Finland) has successfully completed a proof-of-concept study with very encouraging data, showing sustained production of Affimer molecules by the muscle tissue of mice.
Today, Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. These hepatic non-parenchymal cells provide scientists with the building blocks to create more physiologically relevant in vitro models, including co-cultures and 3D cell cultures, for enhanced liver disease research.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the release of a range of anti-vedolizumab antibodies.
Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today announced the launch of StarBright Blue 520 Fluorescent Secondary Antibodies, fluorescent dye–labeled secondary antibodies for use in multiplex western blotting.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague.
SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the introduction of 2view™, a unique detection method optimised for Western blotting, under its Expedeon brand name.
Popular Now
-
Daily News How to Separate the Science From the (Jerk) Scientist -
Daily News Could a Dose of Sunshine Make You Smarter? Moderate ultraviolet light exposure boosts the brainpower of mice thanks to increased production of the neurotransmitter glutamate.
-
The Nutshell Sweden Cancels Agreement With Elsevier Over Open Access A consortium of institutions will not renew its contract with the publisher that ends in June, following the lead of organizations in other countries.
-
The Nutshell Researchers Develop a Drug Against the Common Cold In an in vitro study, the compound completely blocked the replication of rhinoviruses.
© 1986-2018 The Scientist
